CCCC Stock Analysis: Buy, Sell, or Hold?
CCCC - C4 Therapeutics, Inc.
$4.00
0.08 (2.04%)
▲
5d:
+3.36%
30d:
+28.62%
90d:
+53.26%
BUY
MODERATE Confidence
Analysis Updated: Jun 17, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When CCCC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CCCC shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CCCC shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CCCC is currently trading at $4.00, which is considered fair relative to its 30-day fair value range of $3.38 to $4.06.
Technical Outlook: Technically, CCCC is in a strong uptrend. Immediate support is located at $3.44, while resistance sits at $4.45.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.33 (+240.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CCCC is in a strong uptrend. Immediate support is located at $3.44, while resistance sits at $4.45.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.33 (+240.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.38 -
$4.06
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 240.1% below Wall St target ($13.33)
Trading Range Analysis
30-Day Trading Range
$3.38 -
$4.06
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.44
Resistance Level
$4.45
Current Trend
Strong Uptrend
Technical data as of
Jun 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.77
Wall Street Target
$13.33
(+240.1%)
Revenue Growth (YoY)
-15.0%
Profit Margin
-297.8%
Share & Embed Analysis
Last updated: June 18, 2026 1:25 PM ET
Data refreshes hourly during market hours. Next update: 2:25 PM
Data refreshes hourly during market hours. Next update: 2:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCCC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Leonard Reyno
SELL
10000 shares
2026-01-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 67 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$275 | 61 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 62 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 59 HOLD |
